Table 1

Characteristics of patients by survival status and analysis of differences

All patients (n=226)MortalityP value
Yes (n=63)No (n=163)
Neonate< 0.001*
 Yes9655 (57.3)41 (42.7)
 No1308 (6.15)122 (93.85)
Sex0.449*
 Males13637 (27.21)99 (72.79)
 Females9026 (28.89)64 (71.11)
Origin< 0.001*
 Dakar14628 (19.18)118 (80.82)
 Other8035 (43.75)45 (56.25)
Prenatal ultrasound0.002
 Abnormal66 (100)0
 Not done94 (44.44)5 (55.56)
 Normal308 (26.67)22 (73.33)
 Not reported18145 (24.84)136 (75.14)
Gestational age at birth0.002
 Prematurity1411 (78.57)3 (21.43)
 Postmaturity21 (50)1 (50)
 Not reported17844 (24.72)134 (75.28)
 Normal327 (21.87)25 (78.13)
Associated malformation0.002
 Yes139 (69.23)4 (30.77)
 No21354 (25.35)159 (74.65)
Diagnosis< 0.001
 Intestinal atresia55 (100)0
 Esophageal atresia3733 (89.19)4 (10.81)
 Duodenal atresia169 (56.25)7 (43.75)
 Colonic atresia21 (50)1 (50)
 Anorectal malformation699 (13.04)60 (86.96)
 Malrotation293 (13.04)26 (86.96)
 Hirschsprung’s disease643 (4.69)61 (95.31)
 Congenital esophageal stenosis404 (100)
Year of admission0.064*
 2018539 (16.98)44 (83.02)
 20197219 (26.39)53 (73.61)
 202010135 (34.65)66 (65.35)
Mode of admission< 0.001*
 Referral4547 (55.29)38 (44.71)
 Mutation205 (25)15 (75)
 Home12111 (9.09)110 (90.91)
Parental consanguinity0.098*
 Yes219 (42.86)12 (57.14)
 No6421 (32.81)43 (67.19)
 Not reported14133 (23.4)108 (76.6)
  • Bold denotes statistically significant difference.

  • Data were presented as number (percentage).

  • *Pearson’s χ2 test.

  • †Monte Carlo’s exact test.

  • ‡Fisher’s exact test.